Andria Tsang Hambly

Andria Tsang Hambly has a diverse work experience in the field of medical writing. Andria Tsang is currently working at Ventyx Biosciences as a Senior Director of Medical Writing since March 2023. Prior to this, they worked at Arena Pharmaceuticals, Inc. as a Senior Director of Medical Writing from January 2021 to March 2023.

Before their time at Arena Pharmaceuticals, Andria held various positions at Pfizer. Andria Tsang worked as a Director of Medical Writing from April 2018 to January 2021 and as an Associate Director of Medical Writing from October 2016 to March 2018. Andria Tsang also worked briefly at Medivation, which was acquired by Pfizer Inc., as an Associate Director of Medical Writing from March 2016 to September 2016.

Andria's career in medical writing began at Seattle Genetics, where they worked as a Senior Manager of Medical Writing from March 2013 to February 2016 and as a Medical Writer from March 2008 to February 2013.

Andria Tsang also gained experience as an Independent Consultant, working as a Medical Writing Consultant from September 2006 to February 2008. Prior to that, Andria worked as a Medical Writer at ICOS Corporation from July 2006 to April 2007.

Andria's earlier work experience includes positions at the University of California, San Diego - Moores Cancer Center as a Manager of Protocol Development from March 2005 to May 2006, at CureSearch - Children's Oncology Group as a Scientific Writer/Protocol Coordinator from October 2003 to February 2005, and at Chugai Pharma USA as a Research Associate from July 2002 to August 2003.

Andria Tsang Hambly completed their Bachelor of Science, Honours degree in Biochemistry at Western University. Later, they pursued their Masters of BioSciences degree at Keck Graduate Institute from 2000 to 2002.